# Exploring the Anti-inflammatory Properties of Cannabis and Their Relevance to Insulin Sensitivity

> **NCT04114903** · — · COMPLETED · sponsor: **University of Colorado, Boulder** · enrollment: 255 (actual)

## Conditions studied

- Type 2 Diabetes
- Obesity
- Cannabis Use
- Insulin Sensitivity

## Interventions

- **OTHER:** Study A: Single use of cannabis flower product
- **OTHER:** Study B: Ad libitum cannabis use for four weeks or no cannabis use

## Key facts

- **NCT ID:** NCT04114903
- **Lead sponsor:** University of Colorado, Boulder
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-08
- **Primary completion:** 2024-12-01
- **Final completion:** 2024-12-01
- **Target enrollment:** 255 (ACTUAL)
- **Last updated:** 2024-12-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04114903

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04114903, "Exploring the Anti-inflammatory Properties of Cannabis and Their Relevance to Insulin Sensitivity". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04114903. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*